Molecure S.A.
MOC.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | 2,919,000% | -100% | 1,878,262.3% | – |
| Cost of Goods Sold | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Gross Profit | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | -16.8% | -4,101,610% | -0.3% | -693,272.5% |
| R&D Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| G&A Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| SG&A Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Operating Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Operating Income | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | -1,151.3% | -32,128,045% | -584.4% | -3,441,074.8% |
| Other Income/Exp. Net | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Pre-Tax Income | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| Tax Expense | PLN 0 | PLN 0 | -PLN 0 | PLN 0 |
| Net Income | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | -1,071.8% | -28,373,117% | -180.2% | -3,410,639% |
| EPS | -1.55 | -1.69 | -2.56 | -0.98 |
| % Growth | 8.3% | 34% | -161.2% | – |
| EPS Diluted | -1.55 | -1.69 | -2.56 | -0.98 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Interest Expense | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Depreciation & Amortization | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| EBITDA | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| % Margin | -937.8% | -25,505,806% | -423.9% | -3,332,504.8% |